Suppr超能文献

血管性血友病因子在血小板血栓形成中的作用。

Role of von Willebrand factor in platelet thrombus formation.

作者信息

Ruggeri Z M

机构信息

Roon Research Center for Arteriosclerosis and Thrombosis, Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA.

出版信息

Ann Med. 2000 Dec;32 Suppl 1:2-9.

Abstract

Haemostasis is the process that arrests bleeding from wounds, preventing blood from flowing outside of the vascular bed. Thrombosis is an abnormal condition in which the vascular lumen becomes occluded by a mass constituted primarily of aggregated platelets and polymerized fibrin. These thrombi impede the normal flow of circulating blood, becoming the acute cause of diseases that represent a great health concern in the developed world. Haemostasis and thrombosis are two aspects of the same function, ie the biological response to vascular injury leading to formation of a thrombus, which is platelet-rich specifically in the arteries. In either situation, von Willebrand factor is a crucial participant in the process as its main biological activity is to support platelet adhesion and aggregation in vessels where rapid blood flow challenges the firm attachment of thrombi to the vascular wall or exposed extravascular tissues. Advances in understanding the structure and function of von Willebrand factor indicate that this protein, for its unique biomechanical properties, may be a potentially useful target of antithrombotic drugs.

摘要

止血是阻止伤口出血、防止血液流出血管床的过程。血栓形成是一种异常情况,其中血管腔被主要由聚集的血小板和聚合纤维蛋白构成的团块阻塞。这些血栓阻碍循环血液的正常流动,成为在发达国家引起重大健康问题的疾病的急性病因。止血和血栓形成是同一功能的两个方面,即对血管损伤的生物学反应导致血栓形成,血栓在动脉中富含血小板。在任何一种情况下,血管性血友病因子都是该过程中的关键参与者,因为其主要生物学活性是在快速血流对血栓与血管壁或暴露的血管外组织的牢固附着构成挑战的血管中支持血小板黏附和聚集。对血管性血友病因子结构和功能的认识进展表明,这种蛋白质因其独特的生物力学特性,可能是抗血栓药物的潜在有用靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验